The Next Phase of Real-World Clinical Experience with Alefacept: The AWARE-2 Registry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Next Phase of Real-World Clinical Experience with Alefacept: The AWARE-2 Registry

Published:2009-11 Issue:6_suppl Volume:13 Page:S148-S152
ISSN:1203-4754
Container-title:Journal of Cutaneous Medicine and Surgery
language:en
Short-container-title:J Cutan Med Surg

Author:

Searles Gordon¹,Bissonnette Robert¹,Landells Ian¹,Shear Neil H.¹

Affiliation:

1. From the Keystone Dermatology Institute, Edmonton, AB; Innovaderm Research, Montreal, QC; Nexus Clinical Research, St. John's, NL; and Department of Medicine, Division of Dermatology, University of Toronto, Toronto, ON

Publisher

SAGE Publications

Subject

Dermatology,Surgery

Link

http://journals.sagepub.com/doi/pdf/10.2310/7750.2009.00033

Reference12 articles.

1. An International, Randomized, Double-blind, Placebo-Controlled Phase 3 Trial of Intramuscular Alefacept in Patients With Chronic Plaque Psoriasis

2. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis

3. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis

4. An integrated analysis of thirteen trials summarizing thelong-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Alefacept Safety;Journal of Cutaneous Medicine and Surgery;2009-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP